Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 4, No 1 (2012) New possibilities in the prevention of stroke in atrial fibrillation Abstract  similar documents
Vladimir Anatolyevich Parfenov, S V Verbitskaya
"... and warfarin. The trial has indicated that the use of dabigatran in a dose of 150 mg twice daily results ..."
 
Vol 6, No 3 (2014) The risk factors and prevention of stroke in atrial fibrillation Abstract  similar documents
V. A. Parfenov, S. V. Verbitskaya
"... randomized trials that show that novel oral anticoagulants (dabigatran, rivaroxaban, apixaban) are as good ..."
 
Vol 5, No 2 (2013) Dabigatran experience in primary and secondary prevention of cardioembolic stroke Abstract  similar documents
Maksim Alekseyevich Domashenko, M Yu Maksimova, D Z Korobkova, M E Gafarova
"... The review of novel oral anticoagulants (dabigatran, rivaroxaban and apixaban) in stroke prevention ..."
 
Vol 7, No 4 (2015) Topical issues of the efficiency and safety of using the first direct thrombin inhibitor in real clinical practice Abstract  similar documents
A. V. Fonyakin
"... in diabetic patients receiving dabigatran 150 mg twice daily than in those treated with warfarin ..."
 
Vol 6, No 2 (2014) Dabigatran etexilate for nonvalvular atrial fibrillation in real practice and promises for its use to prevent stroke Abstract  similar documents
A.V. Fonyakin
"... , one of which is dabigatran. A wealth of world clinical experience with dabigatran has confirmed its ..."
 
Vol 7, No 2 (2015) The fifth anniversary of clinical use of new oral anticoagulants in non-valvular atrial fibrillation Abstract  similar documents
A. V. Fonyakin
"... a new page in oral anticoagulant therapy aimed at preventing thromboembolic events in AF. Dabigatran ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" Secondary prevention of stroke in atrial fibrillation, use of apixaban: ARISTOTLE, AVERROES studies Abstract  similar documents
V.A. Parfenov, S.V. Verbitskaya
"... – dabigatran. Presented results ARISTOTLE study, where have defined preference apixaban vs warfarin ..."
 
Vol 5, No 2S (2013): Special issue "Stroke" Current approaches to antithrombotic therapy in patients with cardioembolic stroke Abstract  similar documents
Oleg Ivanovich Vinogradov, A N Kuznetsov, N V Rybalko
"... заболеваний печени. Дабигатран назначали дважды в день в фиксирован- ной дозе 110 или 150 мг, доза варфарина ..."
 
Vol 8, No 4 (2016) GLOBAL CLINICAL PRACTICE AND PERSONALIZED CHOICES FOR ORAL ANTICOAGULANT THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Fonyakin, L. A. Geraskina
"... statistically significantly lower only in the dabigatran 150 mg group than in the warfarin group. The rate ..."
 
Vol 8, No 1 (2016) Hemorrhagic stroke and oral anticoagulants: What is to be done? Abstract  similar documents
M. A. Domashenko
"... discusses medical treatment in patients with HS during therapy with vitamin K antagonists (warfarin ..."
 
Vol 6, No 4 (2014) Current guidelines and prospects for using novel oral anticoagulants for nonvalvular atrial fibrillation Abstract  similar documents
A. V. Fonyakin
"... anticoagulants (NOACs), such as dabigatran, rivaroxaban, and apixaban. World clinical experience with NOACs in AF ..."
 
Vol 4, No 3 (2012) A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation Abstract  similar documents
Andrei Viktorovich Fonyakin, L A Geraskina
"... in the prevention of thromboembolic events in AF. More than 60 years, only warfarin and other vitamin K antagonists ..."
 
Vol 10, No 3 (2018) Current strategies to improve the efficiency and safety of prevention and treatment of embolic stroke in non-valvular atrial fibrillation: possibilities of neutralizing therapy Abstract  similar documents
S. N. Yanishevsky
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy Abstract  similar documents
S. N. Yanishevsky
 
Vol 5, No 4 (2013) Cardioembolic stroke: a variety of causes and current approaches to its prevention Abstract  similar documents
Lyudmila Aleksandrovna Geraskina
"... превосходящими варфарин (дабигатрана этексилат 150 мг 2 раза в сутки) в профилактике тромбоэмболических ..."
 
Vol 7, No 1 (2015) Cardioembolic stroke Abstract  similar documents
I. V. Damulin, D. A. Andreev, Z. K. Salpagarova
"... выше в группе дабигатрана 150 мг по сравнению с группой варфарина. Эффективность и безопасность ..."
 
Vol 6, No 1 (2014) Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations Abstract  similar documents
A.V. Fonyakin, L.A. Geraskina
"... and evaluates the potential of rivaroxaban as an alternative to warfarin. Rivaroxaban is shown to be a promising ..."
 
Vol 1, No 2 (2009) ANTITHROMBOTIC THERAPY IN THE PREVENTION OF RECURRENT ISCHEMIC STROKE Abstract  similar documents
Andrey Vladimirovich Fonyakin, Andrey Vladimirovich Fonyakin
"... вторичной профилактики некар- диоэмболического инсульта. При этом наиболее широко испытанным явился варфарин ..."
 
Vol 5, No 4 (2013) Venous thromboses and thromboembolism in acute stroke: risk factors, diagnosis, treatment, and prevention Abstract  similar documents
Andrei Viktorovich Fonyakin, L A Geraskina
"... продемонстрировала сопоставимую эффективность и меньший риск кровотечений при лечении дабигатраном (150 мг 2 раза в ..."
 
Vol 3, No 1 (2011) International recommendations for the secondary prevention of ischemic strokeand their realization in outpatient practice  similar documents
Vladimir Anatol'evich Parfenov, S V Verbitskaya, Vladimir Anatolyevich Parfenov, S V Verbitskaya
"... – дабигатрана, при- менение которого не требует постоянного контроля МНО. В сравнительном исследовании варфарина ..."
 
Vol 2, No 2 (2010) Clinical experience in using cereton in ischemic stroke and dyscirculatory encephalopathy Abstract  similar documents
Lyubov Petrovna Ponomareva, N F Timoshkina, L N Sarantseva, A A Bulanov
"... , which is based on the normalization of blood pressure and the use of antiplatelet agents or warfarin ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" Cryptogenic stroke Abstract  similar documents
N.A. Shamalov, M.A. Kustova
"... дабигатран эффективны так же, как варфарин, в качестве профилактики инсульта у пациентов с ФП и име- ют ..."
 
Vol 3, No 4 (2011) Actual directions in the primary prevention of ischemic stroke Abstract  similar documents
Andrei Viktorovich Fonyakin, L A Geraskina
"... . Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139—51. 39. Patel M ..."
 
Vol 5, No 2 (2013) The key areas of medical therapy for ischemic stroke Abstract  similar documents
Andrei Viktorovich Fonyakin, L A Geraskina
"... вторичная профилактика, дабигатран. Контакты: Максим Алексеевич Домашенко mdomashenko@gmail.com Dabigatran ..."
 
Vol 3, No 1 (2011) The differential diagnosis and treatment of depressive disorders in menopausal women Abstract  similar documents
Nina Arkad'evna Tyuvina, Nina Arkadyevna Tyuvina
"... in particular, can manifest themselves in this period. The paper presents the results of examining 150 women ..."
 
Vol 5, No 4 (2013) Outpatient management after severe stroke with dementia Abstract  similar documents
Natalia Vyacheslavovna Pizova
"... - циловая кислота – АСК (аспирин, кардиомагнил, тромбо- АСС) по 75–150 мг/сут, клопидогрель (плавикс) по 75 ..."
 
Vol 2, No 4 (2010) Management of patients with back pain in outpatient practice Abstract  similar documents
O N Gerasimova, Vladimir Anatol'evich Parfenov, O N Gerasimova, Vladimir Anatolyevich Parfenov
"... of back pain only in 6 (3.8%). Drug therapy using Movalis in 150 patients with acute, subacute, chronic ..."
 
Vol 11, No 1 (2019) Management of patients with acute back pain now and 10 years ago Abstract  similar documents
V. A. Parfenov, E. Yu. Kalimeeva, О. N. Gerasimova
"... men) (mean age, 50.7±17.6 years) at present and 70 patients (40 women and 30 men) (mean age, 46.5±15.0 ..."
 
Vol 2, No 2 (2010) Acetylsalicylic acid in the prevention and treatment of ischemic stroke Abstract  similar documents
Andrey Vladimirovich Fonyakin
"... событий в широком диа- пазоне терапевтической дозы (50—1300 мг/сут), хотя вы- сокие дозы (более 150 мг ..."
 
Vol 4, No 2 (2012) Secondary prevention of ischemic stroke: from recommendations to real clinical practice Abstract  similar documents
V A Shandalin, A V Fonyakin, L A Geraskina
"... подавляющем большинстве наблюдений — варфарин) при наличии пря- мых показаний (ФП, протезированный клапан ..."
 
Vol 5, No 2S (2013): Special issue "Stroke" Management of a post-stroke patient Abstract  similar documents
Vladimir Anatolyevich Parfenov, S V Verbitskaya
"... - диомагнил, тромбоАСС) по 75–150 мг/сут, клопидогрель (плавикс) по 75 мг/сут, комбинация 200 мг дипиридамола ..."
 
Vol 1, No 2 (2009) ACUTE BACK PAIN IN THE OUTPATIENT SETTING AND ITS TREATMENT WITH MYDOCALM AND MIRLOX Abstract  similar documents
S V Verbitskaya, Vladimir Anatol'evich Parfenov, K N Borisov, A V Verbitskaya, Vladimir Anatolyevich Parfenov, K N Borisov
"... and mydocalm in a dose of 150 mg thrice daily. As a result of therapy, back pain disappeared or diminished ..."
 
Vol 3, No 4 (2011) Pharmacoeconomic analysis of the use of movalis (meloxicam) in patients with nonspecific back pain Abstract  similar documents
O N Gerasimova, Vladimir Anatolyevich Parfenov
"... The paper analyzes the use of movalis (meloxicam) in 150 patients with nonspecific back pain ..."
 
Vol 1, No 3-4 (2009) TREATMENT FOR ACUTE NONSPECIFIC BACK PAIN IN OUTPATIENT PRACTICE Abstract  similar documents
O N Gerasimova, Vladimir Anatol'evich Parfenov, O N Gerasimova, Vladimir Anatolyevich Parfenov
"... Seventy patients (40 females and 30 males; mean age 46,5±15,0 years) with acute nonspecific back ..."
 
No 1S (2016): Analysis of adult patients with epilepsy in the age continuum Abstract  similar documents
V. A. Karlov, O. S. Inozemtseva
"... with main types of epilepsy in relation to age. Patients and methods. The investigation enrolled 150 ..."
 
Vol 8, No 2 (2016) Anosognosia in patients with acute hemispheric ischemic stroke Abstract  similar documents
V. N. Grigoryeva, T. A. Sorokina
"... stroke (IS). Patients and methods 150 patients (83 men and 67 women; mean age, 63.0±9.3 years ..."
 
Vol 8, No 4 (2016) IMPACT OF ANTICOAGULANT THERAPY ON THE INDICATORS OF ARTERIAL STIFFNESS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CARDIOEMBOLIC STROKE Abstract  similar documents
I. A. Zolotovskaya, I. L. Davydkin, I. E. Poverennova, N. P. Romanchuk
"... . Пациенты основной группы (n=48) получали новые пероральные ан- тикоагулянты (ПОАК): дабигатран – 15 (31 ..."
 
Vol 9, No 2 (2017) Antiplatelet therapy strategies for ischemic stroke Abstract  similar documents
M. Yu. Maksimova, A. V. Fonyakin, L. A. Geraskina
"... /сут), хотя высокие дозы (>150 мг) увеличивали риск побочных явлений (язвенное поражение желудочно ..."
 
Vol 6, No 3 (2014) Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis Abstract  similar documents
S. M. Karpov, Z. B. Pazhigova, E. N. Karpova
"... that in the control group, by comprising 147.29±1.19 msec for RRMS, 150.23±1.49 msec for SPMS, and 144.38±2.11 msec ..."
 
Vol 4, No 1 (2012) Antyhypertensive therapy-based secondary prevention of ischemic stroke Abstract  similar documents
Vladimir Anatolyevich Parfenov, S V Verbitskaya, Yu A Starchina
"... антитромбоцитарные средст- ва и статины, для профилактики кардиоэмболического инсульта – антикоагулянты (варфарин ..."
 
Vol 1, No 1 (2009) ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE Abstract  similar documents
I S Yavelov, I S Yalevov
"... . Роль антагонистов витамина К (варфарин) в первичной профилактике ишемического ин- сульта у больных без ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" Arterial hypertension and stroke: cardiac and neurological aspects of secondary prevention Abstract  similar documents
L.A. Geraskina
"... , препаратом выбора является антагонист витамина К варфарин, позволяющий снизить ОР повторно- го инсульта на 65 ..."
 
Vol 5, No 4 (2013) Platelet antiaggregants in the treatment and prevention of ischemic stroke Abstract  similar documents
Andrei Viktorovich Fonyakin
"... терапевти- ческой дозы (50–1300 мг/сут), хотя высокие дозы (>150 мг) увеличивают риск побочных явлений ..."
 
Vol 5, No 2S (2013): Special issue "Stroke" Management of patients with post-stroke dementia Abstract  similar documents
Svetlana Viktorovna Verbitskaya
"... случае кардиоэмболического инсульта при- меняют варфарин в суточной дозе 2,5–10 мг под контролем ..."
 
Vol 6, No 1 (2014) The use of neurocytoprotectors to improve rehabilitation of patients after cerebrovascular accident Abstract  similar documents
V.V. Kovalchuk
"... , дипиридамол, клопидогрел, варфарин, ривароксабан, дабигатран; **** – аторвастатин; ***** – амитриптилин ..."
 
Vol 4, No 4 (2012) Subtypes of ischemic cerebral circulation disorders at young age: diagnosis and treatment Abstract  similar documents
Natalia Vyacheslavovna Pizova
"... мг (или 150 мг) ацетилсалициловой кислоты и 15,2 мг (или 30,39 мг) гидроксида магния. Гидроокись ..."
 
Vol 1, No 3-4 (2009) ACETYLCALICYLIC ACID AND PREVENTION OF STROKE IN HIGH-RISK GROUP PATIENTS Abstract  similar documents
Igor' Semenovich Yavelov, Igor Semenovich Yavelov
"... . 17. Hurlen M., Abdelnoor M., Smith P. Warfarin, aspirin, or both after myocardial infarction. N Engl ..."
 
Vol 6, No 2 (2014) Heart diseases and strokes in young people Abstract  similar documents
N.V. Pizova
"... %, в средних дозах (160–325 мг) – 26%, а в низ- ких дозах (75–150 мг) – 32%. При этом низкие дозы более ..."
 
Vol 1, No 3-4 (2009) ANTITHROMBOCYTIC THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
Andrey Viktorovich Fonyakin, L A Geraskina, Andrey Viktorovich Fonyakin, L A Geraskina
"... протезированных клапанах. Препаратом выбора является варфарин, высокая те- рапевтическая активность которого ..."
 
Vol 1, No 1 (2009) THERAPY FOR EPILEPSY IN MIDDLE-AGED AND ELDERLY PATIENTS Abstract  similar documents
P N Vlasov, O V Andreeva, P N Vlasov, O V Andreyeva
"... , нифеди- пина, гормональных контрацептивов, пропранолола, теофиллина, варфарина. Неоднозначный эффект ..."
 
1 - 50 of 223 Items 1 2 3 4 5 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)